Meta Platforms, Inc.·4

Mar 24, 9:33 PM ET

Mahoney Curtis J. 4

4 · Meta Platforms, Inc. · Filed Mar 24, 2026

Research Summary

AI-generated summary of this filing

Updated

Meta (META) Chief Legal Officer Curtis J. Mahoney Receives Award

What Happened

  • Curtis J. Mahoney, Meta's Chief Legal Officer, was granted a series of derivative awards (reported as "A" — grant/award) on March 20, 2026. The grants total 163,469 derivative shares across seven tranches (3,202; 4,517; 7,335; 24,386; 38,873; 62,346; 22,810). Each grant is reported with an acquisition price of $0.00, indicating option/award grants rather than an open‑market purchase or sale. No exercise or sale of shares was reported in this filing.

Key Details

  • Transaction date: 2026-03-20; Form 4 filed 2026-03-24 (timely filing).
  • Reported acquisition price: $0.00 (derivative awards/options).
  • Total shares granted: 163,469 (broken out by tranche above).
  • Shares owned after transaction: not specified in the provided data.
  • Footnote highlights:
    • F1: Tranches vest if Meta’s Class A share price meets/exceeds the applicable exercise price at any time during the "Price Vesting Period" through Feb 14, 2028 (price-vesting condition).
    • F2: Any tranches not price‑vested by Feb 15, 2028 will vest on a time-based schedule (6/16ths on Feb 15, 2028, then 1/16th quarterly, final 1/16th on Aug 15, 2030), subject to continued service.
  • Transaction type: award/grant of derivative securities (not a purchase or sale).

Context

  • These are conditional option/award grants — they do not represent immediate cash paid or shares received for sale. Vesting depends on stock-price performance during the price-vesting window and continued employment, and any remaining unvested portion follows a multi-year time-based vesting schedule.
  • For retail investors: awards and option grants are common executive compensation/retention tools and are not the same signal as an insider buying shares. They can be material to dilution and long‑term incentive alignment but do not indicate immediate insider buying or selling activity.

Insider Transaction Report

Form 4
Period: 2026-03-20
Mahoney Curtis J.
Chief Legal Officer
Transactions
  • Award

    Stock Options (right to buy)

    [F1][F2]
    2026-03-20+3,2023,202 total
    Exercise: $1116.08Exp: 2031-03-19Class A Common Stock (3,202 underlying)
  • Award

    Stock Options (right to buy)

    [F1][F2]
    2026-03-20+4,5174,517 total
    Exercise: $1393.87Exp: 2031-03-19Class A Common Stock (4,517 underlying)
  • Award

    Stock Options (right to buy)

    [F1][F2]
    2026-03-20+7,3357,335 total
    Exercise: $1724.41Exp: 2031-03-19Class A Common Stock (7,335 underlying)
  • Award

    Stock Options (right to buy)

    [F1][F2]
    2026-03-20+24,38624,386 total
    Exercise: $2114.87Exp: 2031-03-19Class A Common Stock (24,386 underlying)
  • Award

    Stock Options (right to buy)

    [F1][F2]
    2026-03-20+38,87338,873 total
    Exercise: $2573.06Exp: 2031-03-19Class A Common Stock (38,873 underlying)
  • Award

    Stock Options (right to buy)

    [F1][F2]
    2026-03-20+62,34662,346 total
    Exercise: $3107.44Exp: 2031-03-19Class A Common Stock (62,346 underlying)
  • Award

    Stock Options (right to buy)

    [F1][F2]
    2026-03-20+22,81022,810 total
    Exercise: $3727.12Exp: 2031-03-19Class A Common Stock (22,810 underlying)
Footnotes (2)
  • [F1]The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date.
  • [F2]Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date.
Signature
/s/ Erin Guldiken, attorney-in-fact for Curtis J. Mahoney|2026-03-24

Documents

1 file
  • 4
    dp243962_4-mahoney.xmlPrimary

    FORM 4